We recently reported that forced expression of basic helix-loop-helix transcription factor Dec1 accelerated chondrogenic differentiation of mesenchymal stem cells ( 
Introduction
Basic helix-loop-helix transcription factor Dec1 (Stra13/Bhlhb2), which was previously identified as a differentially expressed transcript in chondrocytes (Shen et al., 1997) , can bind to the CACGTG E-boxes and repress transcription from the target genes (Hamaguchi et al., 2004; Honma et al., 2002; Kawamoto et al., 2004; Li et al., 2003; Sato et al., 2004; St-Pierre et al., 2002; Zawel et al., 2002) . Overexpression of Dec1 enhanced chondrogenic differentiation of mouse ATDC5 cells and rabbit bone marrow mesenchymal stem cells (MSC) (Shen et al., 2002) , but inhibited adipogenic differentiation of mouse 3T3-L1 cells (Yun et al., 2002) ; stable expression of DEC2 in mouse C2C12 cells inhibited myogenic differentiation by interacting with MyoD (Azmi et al., 2004) . Dec1 also plays a part in circadian rhythm regulation by repressing CLOCK/BMAL1-induced promoters (Butler et al., 2004; Hamaguchi et al., 2004; Honma et al., 2002; Kawamoto et al., 2004; Li et al., 2004; Noshiro et al., 2004; . During endochondral bone development in mouse tibia, Dec1 mRNA expression was observed from E15.5 in post-mitotic hypertrophic chondrocytes, colocalizing with collagen X mRNA (Maclean and Kronenberg, 2004) . At E15.5-E18.5, Dec1 was also expressed in the primary spongiosa, where Dec1 may be involved in primary bone formation.
Since Dec1 is expressed in various tissues and induced by various growth factors or hypoxia (Boudjelal et al., 1997; Fujimoto et al., 2001; Miyazaki et al., 2002; Rossner et al., 1997; Shen et al., 2001; Shen et al., 1997) , it may be involved in the control of differentiation in numerous tissues. Since MSC can give rise to osteoblasts, chondrocytes, myocytes, and adipocytes (Muraglia et al., 2000; Pittenger et al., 1999) , these cells may be useful for analysis of lineage determination and the differentiation steps (Matsubara et al., 2004; Pittenger et al., 1999; Tsutsumi et al., 2001 ). Among various transcription factors involved in osteogenic differentiation, Runx2 plays a central role in bone formation: In Runx2 null mice, osteoblast differentiation was arrested in both the endochondral and intramembranous skeleton (Ducy et al., 1997; Komori et al., 1997; Mundlos et al., 1997; Otto et al., 1997) . For adipogenic differentiation, the nuclear hormone receptor PPAR plays a crucial role in the function of many fat cell-specific genes (Rosen and Spiegelman, 2001 ). However, numerous other regulatory molecules are likely to be involved in the complex processes of osteogenic and adipogenic differentiation, stage-dependently. To clarify the roles of Dec1 in differentiation of mesenchymal cells, we examined the effects of Dec1 overexpression on osteogenic and adipogenic differentiation of bone marrow MSC:
Forced expression of Dec1 up-regulated bone-related gene expression and enhanced calcification, and it suppressed adipogenic differentiation of MSC.
Materials and methods

Cell culture and adenovirus infection
Human MSC were purchased from BioWhittaker (Walkersville, MD) and cultured in Dulbecco's modified Eagle's medium-high glucose (DMEM) containing 10% fetal bovine serum (FBS), 100 units/ml penicillin, and 0.1 mg/ml streptomycin at 37°C in 5% CO 2 atmosphere. For osteogenic induction, MSC were plated at a density of 1 10 4 cells/cm 2 in 16-mm wells coated with type I collagen. For adipogenic induction, MSC were plated at a density of 2 10 4 cells/cm 2 in 16-mm wells.
Twenty-four hours after seeding the cells, infection of these cells with adenovirus expressing human Dec1 (ad-Dec1) or adenovirus expressing LacZ (ad-LacZ) was performed at a multiplicity of infection (MOI) of 50 or 100 p.f.u/cell, as described previously (Shen et al., 2002) . Adenovirus carrying the LacZ gene was generously supplied by Dr. Kohei Miyazono (The University of Tokyo) (Fujii et al., 1999) . Six hours later, the culture medium was replaced with an induction medium suitable for osteogenic or adipogenic differentiation.
Osteogenic induction
Thirty hours after plating, MSC were transferred to the osteogenic induction medium (Os-medium), an -minimal essential medium ( MEM) supplemented with 10% FBS, 0.1 M dexamethasone, 10 mM -glycerophosphate, and 50 M ascorbic acid-2-phosphate (Pittenger et al., 1999) . As a control, MSC were incubated in MEM supplemented with 10% FBS alone (medium-A).
Adipogenic induction
For adipogenic differentiation, MSC were transferred to DMEM supplemented with 10% FBS, 0.1 M dexamethasone, 0.2 mM indomethacin, 10 g/ml insulin, and 0.5 mM 3-isobutyl-1-methyl-xanthine (the adipogenic induction medium) (Pittenger et al., 1999) . After 3 days, this medium was replaced with DMEM supplemented with 10% FBS and 10 g/ml insulin (the adipogenic maintenance medium), and the cells were cultured for 24 h in the new medium. Then, the induction/maintenance cycle for adipogenic induction was repeated.
RNA extraction and real-time quantitative RT-PCR
Total RNA was extracted from cultured cells using TRIzol reagent (Invitrogen, Carlsbad, CA) and subjected to real-time quantitative RT-PCR analysis using ABI Prism 7900 sequence detection system (Applied Biosystems, Foster City, CA) with TaqMan probes and primers shown in Table 1 . TaqMan probe and primers for PTH receptor and GAPDH were obtained from Applied Biosystems. The values for mRNA levels, relative to internal control GAPDH, represent the mean ± SEM for three wells. The experiments were repeated 2 to 4 times and similar results were obtained each time.
RNA interference
Twenty-four hours after MSC were seeded at a density of 5 10 3 cells/cm 2 in 12-well plates, the cells were transfected with Dec1 siRNA (DHARMACON, CO) or nonsilencing control siRNA (QIAGEN, CA) using Trans-IT TKO transfection reagent (Mirus, WI). After 48 h incubation, the culture medium was replaced with Os-medium for osteogenic induction.
ALPase staining
Cells were fixed with 3.5% formaldehyde and stained using ALPase staining kit (Muto pure chemical, Tokyo, Japan). The stained cells were rinsed with deionized water and dried overnight.
Alizarin red and von Kossa staining
Fixed cells were incubated with 1% Alizarin red-S (Sigma, St. Louis, MO) for 1 h at room temperature. Alternatively, fixed cells were exposed to sunlight for 30 min in the presence of 5% silver nitrate, and then incubated with 5% sodium thiosulfate for 5 min (von Kossa staining). The stained cells were rinsed with deionized water and dried overnight.
Calcium content
After MSC were rinsed with PBS, calcium in the cell cultures was dissolved in 0.1 M HCl at 4°C overnight. Calcium content of each sample was determined using Calcium C kit (Wako pure chemical, Osaka, Japan).
Oil red-O staining
MSC fixed with 3.5% formaldehyde were incubated with 0.3% Oil red-O (Sigma)
for 1 h at room temperature. The stained cells were rinsed with deionized water and dried overnight. Lipid drop areas stained with Oil red-O were measured using NIH image program (RSB, NIMH/NIH, Bethesda, MD).
Results
Changes in Dec1 mRNA levels during osteogenic differentiation of MSC Osteogenic differentiation of human MSC was induced by Os-medium. After osteogenic induction, Dec1 mRNA expression began to increase on day 5 and reached a peak on day 14 (Fig. 1A) . In these cultures, mRNA levels of ALPase and PTH receptor started to increase on day 2, reaching a peak on day 14 ( Fig. 1B and C) ; osteopontin mRNA level increased on days 14 and 21 (Fig. 1D) .
Effect of forced expression of and Dec1 siRNA on osteogenic differentiation of
MSC
To test the effect of Dec1 overexpression in the absence of Os-medium, MSC infected with Dec1-expressing adenovirus (ad-Dec1) were maintained in medium-A.
Forced expression of Dec1 elevated osteopontin mRNA levels at MOI 25 or 50 ( Fig.   2A ) and the increase of osteopontin mRNA levels was significant from day 2 to day 14 compared with infection with LacZ-expressing adenovirus (ad-LacZ) (Fig. 2B) .
Expression of PTH receptor mRNA was also enhanced from day 5 to day 14, while Runx2 expression was not significantly changed. In addition, the Dec1 overexpression raised the activity and mRNA levels of ALPase (Fig. 2C) . However, calcification was not induced by Dec1 overexpression until day 28 (Fig. 2D) .
In further studies, the effect of Dec1 overexpression on bone-related gene expression in MSC cultured in Os-medium was examined. Infection of MSC with adDec1 up-regulated osteopontin mRNA levels from day 2 to day 14 in the presence of Os-medium (Fig. 3A) . The Dec1 overexpression enhanced the activity and mRNA expression of ALPase (Fig. 3B) . The effect of Dec1 overexprssion on mRNA levels of osteopontin was much greater than that of Os-medium on day 7, and Dec1 overexpression and Os-medium showed a synergistic or additive effect on day 7 or 14 ( Fig. 3C) . Furthermore, Dec1 overexpression promoted calcification of MSC cultures in Os-medium: The calcium level in the cultures overexpressing Dec1 on day 25 was 5 times as high as that in control cultures expressing LacZ (Fig. 4A) . The accelerated calcification was confirmed by Alizarin red or von Kossa staining (Fig. 4B) . Moreover, PTH receptor expression induced by Os-medium was attenuated by Dec1 siRNA on days 5 and 7 (Fig 4) , showing the involvement of Dec1 in osteogenic differentiation process of MSC.
Suppression of adipogenic differentiation of MSC by Dec1 overexpression
To explore the role of Dec1 in adipogenesis, expression levels of Dec1 during adipogenic differentiation of MSC were examined: After adipogenic induction, mRNA levels for Dec1 markedly decreased on days 3 and 7 (Fig. 5A ), but not on day 14, which suggested that the expression of Dec1 at high levels may suppress adipogenic differentiation. To test this hypothesis, we looked at whether Dec1 overexpression would inhibit adipogenic differentiation of MSC: Infection with ad-Dec1 transiently lowered mRNA levels of PPAR until day 7 (Fig. 5B) , and the Dec1 overexpression also suppressed lipid accumulation on days 3 and 7, but not on day 14 (Fig. 5C ), although Dec1 mRNA levels remained high on day 14 (Fig. 5D ). These results indicate that Dec1 lowers the rate of adipogenic differentiation only in the early stage.
Discussion
Osteogenic differentiation of MSC is inducible in Os-medium containing dexamethasone, -glycerophosphate, and ascorbic acid (Matsubara et al., 2004; Pittenger et al., 1999; Tsutsumi et al., 2001 ): ALPase activity and calcium levels increase a week after osteogenic induction, and the differentiation continues to progress at least until day 21. In the present study, we demonstrated that expression of Dec1 -as well as bone-related genes -was up-regulated in the induced MSC. Furthermore, forced expression of Dec1 in uninduced MSC up-regulated the expression of some bonerelated proteins -such as osteopontin, PTH receptor and ALPase -and accelerated the osteogenic differentiation and calcification in MSC cultures under osteogenic conditions. Decrease in the Dec1 mRNA level by about 60% in the presence of siRNA resulted in the suppression of PTH receptor, but it did not decrease the level of osteopontin or ALPase under these culture conditions (data not shown). Furthermore, Dec1 overexpression alone did not induce calcification in MSC cultures. Taken together, these observations suggest that Dec1 is not essential for osteogenesis, but is involved in some aspects of the osteogenic differentiation process.
Since Dec1 overexpression had little effect on expression of Runx2 in MSC, the Dec1-induced osteogenesis could not be attributed to the induction of Runx2. In fact, in vivo studies using Runx2-transgenic mice showed that overexpression of Runx2 in osteoblasts inhibited their maturation (Liu et al., 2001 ), while Runx2 is essential for osteogenic differentiation in the early stage. These findings suggest that Runx2 stimulates or inhibits osteogenic differentiation of MSC stage-dependently. Some other transcriptional regulators must therefore be involved in the differentiation process of MSC: Dec1 could be one of these transcription factors, although Dec1 alone cannot induce the whole osteogenic differentiation program.
A previous study reported that Dec1 functions as an effector for hypoxia-mediated inhibition of adipogenesis via PPAR suppression: Stable expression of Dec1 resulted in nearly complete inhibition of adipocyte differentiation of a mouse adipogenic cell line -3T3-L1 cells (Yun et al., 2002) . In the present study, we found that expression levels of for Dec1 (A), ALPase (B), PTH receptor (C) or osteopontin (D) relative to GAPDH mRNA levels. P-values were calculated by using the Student's t-test (**P < 0.01, *P < 0.05). 
